医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

KYOCERA Begins Research in AI-based Image Recognition to Help Diagnose Skin Diseases and Cancers via Smartphone

2017年08月29日 PM09:07
このエントリーをはてなブックマークに追加


 

KYOTO, Japan

Kyocera Corporation (NYSE:KYO)(TOKYO:6971) announced today that its subsidiary, Kyocera Communication Systems Co., Ltd. (hereafter “KCCS”), has started joint research with the University of Tsukuba to develop an Artificial Intelligence (AI) system capable of detecting melanoma and other skin diseases by analyzing digital images of a patient’s skin. The team aims to commercialize the technology by 2020.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170829005567/en/

Skin disease diagnostic support system and potential applications (Graphic: Business Wire)

Skin disease diagnostic support system and potential applications (Graphic: Business Wire)

Background

Recent developments in AI, image recognition, and IT infrastructure are facilitating great advances in the ability to analyze digital images. In the medical field, where digital imaging is already an essential diagnostic tool, AI-based image recognition offers revolutionary potential. Diagnosing skin diseases from digital images using AI will offer great advantages over conventional practices, which now often depend on the knowledge and experience of a physician.

In Japan, the number of skin cancer patients has approximately doubled*1 from 1999 through 2014. Japan’s Ministry of Health, Labour and Welfare has identified AI as a key technology in the healthcare and medical sector. Because skin cancer treatment outcomes are substantially improved by early diagnosis, better diagnostic technologies are in great demand.

Overview of the Joint Research

KCCS is now working with Professor Manabu Fujimoto and Assistant Professor Yasuhiro Fujisawa (both of the Department of Dermatology, Faculty of Medicine, University of Tsukuba) to develop an image-recognition system accurate enough to distinguish several types of skin malignancies, including melanoma. The next phase of their project will aim for image-based diagnostic support of any skin disease. In addition to helping dermatology specialists, AI-based image recognition could allow accurate diagnoses in rural and remote areas lacking a local clinician, using pictures from smartphones or digital cameras to greatly improve healthcare outcomes.

The project benefits from a database of more than 200 clinical images accumulated over 20 years by the University of Tsukuba Hospital’s Department of Dermatology. The University’s experiences and knowledge including these images will be instrumental in assessing image-based diagnostic accuracy in real-world conditions. Additionally, KCCS will bring unique AI-based image-processing expertise accumulated through Labellio — a cloud-based web service. The service allows any user to create a simple “drag-and-drop” image classifier powered by deep learning.

 

Roles and Timetable

 
KCCS   Development of AI-based image recognition system
University of Tsukuba   Provision of clinical image database;
Assessment of system accuracy and adaptability
 

KCCS and the University of Tsukuba will conduct joint research from March 2017 through March 2018, aiming toward a commercial application in the fiscal year ending March 2020. Furthermore, they plan to develop a system capable of identifying more than 2,000 different skin diseases from digital images by combining their respective resources and expertise in the future.

*1 Based on patient survey by Japan’s Ministry of Health, Labour and Welfare.
Product specifications and launch dates are subject to change without prior notice. All product names and company names mentioned are trademarks or registered trademarks of the respective companies.

About KYOCERA

Kyocera Corporation (NYSE:KYO)(TOKYO:6971) (http://global.kyocera.com/), the parent and global headquarters of the Kyocera Group, was founded in 1959 as a producer of fine ceramics (also known as “advanced ceramics”). By combining these engineered materials with metals and integrating them with other technologies, Kyocera has become a leading supplier of electronic devices, semiconductor packages, printers, copiers, mobile phones, solar power generating systems, cutting tools and industrial components. During the year ended March 31, 2017, the company’s consolidated net sales totaled 1.42 trillion yen (approx. USD12.7 billion). Kyocera appears on the “Top 100 Global Innovators” list by Clarivate Analytics and is ranked #522 on Forbes magazine’s 2017 “Global 2000” list of the world’s largest publicly traded companies.

Kyocera Communication Systems Co., Ltd. (KCCS) is a subsidiary of Kyocera Corporation and a provider of ICT, telecommunications engineering, environment and energy engineering and management consulting services. For more information, visit http://www.kccs.co.jp/english/

View source version on businesswire.com: http://www.businesswire.com/news/home/20170829005567/en/

CONTACT

KYOCERA Corporation (Japan)
Natsuki Doi, +81-(0)75-604-3416
Corporate
Communications
webmaster.pressgl@kyocera.jp
Fax:
+81-(0)75-604-3516

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • CDISC and Cohen Veterans Bioscience Announce Public Review for Post Traumatic Stress Disorder Therapeutic Area User Guide
  • New Data on Automotive, Consumer Health and Consumer Finance from Euromonitor
  • 第6回年次世界患者安全・科学・技術サミットを英国ロンドンで開催へ
  • Sun Pharma Odomzo® (Sonidegib) New Label Approval Shows Sustained Duration of Response of 26 Months in Treatment of Locally Advanced Basal Cell Carcinoma
  • Eagle Pharmaceuticals Licenses Japanese Rights for Bendamustine Hydrochloride Ready-to-dilute and Rapid Infusion Injection Products to SymBio Pharmaceuticals Limited